FLII and neoplasm: The oncogenic functions of CDK12 are proposed to reflect the transcriptional stimulation of, e.g., MYC and EWS/FLI gene expression, while tumor-suppressing functions are proposed to be a consequence of stimulating the expression of, in particular, long genes in the DDR and HR pathways [44,45,47,50].